The human microbiome therapeutics market size was valued at USD 456.2 million in 2022 and is poised to grow at a significant CAGR of 22.3% during the forecast period 2023-29. The primary drivers of the expansion of the global human microbiome market include the increasing applications of microbiome-based products in human health, technological advancements in the microbiome industry, and the increasing number of digestive disorders. The global human microbiome market further reveals that the key players are increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliances to improve market revenue share and gain significant geographic presence across the region.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/human-microbiome-therapeutics-market/    

The human microbiome therapeutics market segmentation:
1) By Product Type: Prebiotics, Probiotics, Symbiotics, Xenobiotics
2) By Application:  Obesity, Diabetes, Autoimmune Disorders, Cancer, Gastrointestinal Disorders, Central Nervous System Disorders, Skin Care and Oral Care, Others

Based on applications, the diabetes segment is expected to account for a larger revenue share in the global human microbiome market, with a value share worldwide. The increasing investment and funding for the research and development sector is the major driver of the global human microbiome market growth. Moreover, technological advancements, the increasing number of clinical trials, unhealthy lifestyles, and the increasing number of digestive disorders will boost the overall growth in the therapeutics segment. The global key market players are also influencing the market through collaborations.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=59592  

North America is expected to increase in the global human microbiome therapeutics market over the forecast period. North America is expanding in the global human microbiome market as a result of bad lifestyles, technological advancements, and an increasing number of microbiome projects. Europe held considerable market share during the estimated period owing to the comprehensive research and development of new applications for the human microbiome and technological advancements.

The human microbiome therapeutics market key players are Enterome Bioscience, Seres Therapeutics, 4D pharma, Second Genome, Vedanta Biosciences, Ferring Pharmaceuticals, ViThera Pharmaceuticals, BiomX, DuPont, Kaleido, YSOPIA Bioscience, Metabiomics, Yakult Honsha, and OptiBiotix.


About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers. Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747